New Medication Treats Drug-Resistant Prostate Cancer in the Laboratory
Endocrine SocietyA new drug called pyrvinium pamoate inhibits aggressive forms of prostate cancer that are resistant to standard drugs, according to a study conducted in an animal model. The results will be presented Monday at The Endocrine Society’s 95th Annual Meeting in San Francisco.